Abstract
Atherosclerosis of the lower limbs may be diagnosed when symptomatic arteriopathy is present, or in association with other diseases or an epidemiological survey. The investigation of symptomatic arteriopathies will be examined here.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abbott WM (1980) Percutaneous transluminal angioplasty. Surgeon’s view. AJR, 135:917–920
Allen-Barker-Hines (1980) Peripheral vascular diseases, 5th edn. Juergens JL, Spittell JA, Fairbairn JF (eds). Saunders, Philadelphia
Baker JD (1978) Post-stress doppler ankle pressures. A comparison of treadmill exercise with two other methods of induced hyperemia. Arch Surg 113:1171–1173
Boucher CA, Brewster DC, Darling RC et al. (1985) Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med 312:389–384
Carter SA (1969) Clinical measurement of systolic pressures in limbs with arterial occlusive disease. JAMA 207:1879–1874
Carter SA (1972) Response of ankle systolic pressure to leg exercise in mild or questionable arterial disease. N Engl J Med 287:578–582
Carter SA (1973) The relationship of distal systolic pressures to healing of skin lesions in limbs with arterial occlusive disease with special reference to diabetes mellitus. Scand J Clin Lab Invest. (Suppl 128) 31:239–243
Carter SA (1981) Arterial auscultation in peripheral vascular disease. JAMA 246:1682–1686
Chilvers AS, Thomas ML, Browse NL (1974) The progression of arteriosclerosis, a radiological study. Circulation 50:402–408
Cormier JM, Fiessinger JN, Capron L (1984) Athérosclérose oblitérante des members inférieurs. Encycl Med Chir (Paris), Cœur-Vaisseaux, 11316 A10, 12–1984
Criqui MH, Coughlin SS, Fronek A (1985) Non- invasively diagnosed peripheral arterial disease as a predictor of mortality; results from a prospective study. Circulation 72:768–773
Criqui MH, Fronek A, Barrett-Connor E et al. (1985) The prevalence of peripheral arterial disease in a defined population. Circulation 71:510–515
Criqui MH, Fronek A, Klauber MR etal. (1985) The sensitivity, specificity and predictive value or traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation 71:516–522
Cronenwett JL, Warner KG, Zelenock GB etal. (1984) Intermittent claudication current results of nonoperative management. Arch Surg 119:430–436
Cutler BS, Wheeler HB, Paraskos JA, Cardullo PA (1981) Applicability and interpretation of electrocardiographic stress testing in patients with peripheral vascular disease. Am J Surg 141:501–506
De Cree J, Leempoels J, Geukens H, Verhaegen H (1984) Placebo-controlled double-blind trail of ketanserin treatment of intermittent claudication. Lancet II:775–779
Duffield RG, Lewis B, Miller NE et al. (1983) Treatment of hyperlipidaemia retards progession of symptomatic femoral atherosclerosis. A randomised controlled trial. Lancet II:639–652
Eskridge JM, Becker GL, Rabe FE et al. (1983) Catheter- related thrombosis and fibrinolytic therapy. Radiology 149:429–432
Fiessinger JN, Aiach M (1983) Utilisation des throm- bolytiques dans les affections artérielles. Agressologie 24:573–577
Fiessinger JN, Vitoux JF, Pernes JM et al. (1986) Complications of local thrombolytic therapy in treatment of peripheral arterial occlusions. AJR 146:157–159
Forconi S. Pieragalli D, Acciavatti A etal. (1984) Positive effect of oral buflomedil on exercise-induced haemo- rhological damage and on claudication distance in peripheral obliterative arterial disease patients. J Int Med Res 12:188–192
Francfort JW, Bigelow PS, Davis JT, Berkowitz HD (1984) Noninvasive techniques in the assessment of lower-extremity arterial occlusive disease. The advantages of proximal and distal thigh cuffs. Arch Surg 119:1145–1148
Franco A, Morzol B, Piquard JF et al. (1978) Valeur de l’irrigraphie dans l’évaluation de la fonction fémo- ropoplitée et distale. J Mal Vasc 3:188–193
Glover JL, Bendick PJ, Jackson VP etal. (1984) Duplex ultrasonography digital subtraction angiography and conventional angiography in assessing carotid atherosclerosis. Arch Surg 119:664–669
Graor RA (1985) Local thrombolysis in the treatment of thrombosed arteries, bypass grafts and arteriovenous fistulas. Vasc Surg 2:406–414
Guidet B. Angel C. Seurot M et al. (1983) Angioplastie endoluminale percutanée des artères iliaques. Résultats immédiats et à distance. Press Med 12:507–511
Hertzer NR, Beven EG, Young JR et al. (1984) Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 199:223–233
Hess H, Miestaschk A, Deischsel G (1985) Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective doubleblind arteriographically controlled trial. Lancet I:415–419
Ingram DM, House AK, Thrompson GH etal. (1982) Beta-adrenergic blockade and peripheral vascular disease. Med J Aust 1:509–511
Jones NAG, De Haas H, Zahavi J. Kakkar VV (1982) A double blind trial of suloctudil v. placebo in intermittent claudication. Br J Surg 69:38–40
Kaufman SL, Chang R, Kadir S et al. (1984) Intraarterial digital subtraction angiography in diagnostic arteriography. Radiology 151:323–327
Levenson JA, Simon AC, Fiessinger JN et al. (1982) Systemic arterial compliance in patients with arteriosclerosis obliterans of the lower limbs. Observations on the effect of intravenous propranolol. Arteriosclerosis 2:266–271
Lezack JD, Carter SA (1973) The relationship of distal systolic pressures to the clinical and angiographic findings in limbs with arterial occlusive disease. Scand J Clin Lab Med (Suppl 31) 31:97–101
Lynch TG, Hobson RW, Wright CB etal. (1984) Interpretation of doppler segmental pressures in peripheral vascular occlusive disease. Arch Surg 119:465–467
Macpherson DS, James DC, Bell PRF (1980) Is aortography abused in lower-limb ischaemia, Lancet II:80–82
Marinelli MR, Beach KW, Glass MJ etal. (1979) Non- invasive testing vs clinical evaluation of arterial disease. A prospective study. JAMA 241:2031–2034
Peronneau P, Xhaard M, Diebold B etal. (1976) Débi- tmétrie transcutanée par vélocimétrie ultrasonore Doppler à émission puisée. Premières applications cliniques. Nouv Presse Med. 5:2547
Petiau JC, Lancelin B. Guermonprez JL et al. (1978) Artériopathie des membres inférieurs: intérét de l’épreuve d’effort. Nouv Presse Med 7:2074
Porter JM, Cutler BS, Lee BY et al. (1982) Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart H 104:66–72
Ratliff DA, Chant ADB, Webster JHH (1984) Predicting of amputation wound healing: the role of transcutaneous p02 assessment. Br J Surg 71:219–222
Raynaud A, Seurot M, Angel C et al. (1983) Indications actuelles de l’angiographie numérique par voie veincise dans l’étude des axes ilio-fémoraux. Press Méd 12:1641–1644
Reunanen A, Takkunen H, Aromaa A. (1982) Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 21:249–256
Sicard GA. Schier JJ, Totty WG etal. (1985) Thrombolytic therapy for acute arterial occlusion. Vasc Surg 2:65–78
Sorlie D, Myhre K (1978) Effects of physical training in intermittent claudication. Scand J Clin Lab Invest 38:217–222
Strandness DE (1983) Noninvasive evaluation of arteriosclerosis. Comparison of methods. Arteriosclerosis 3:103–116
Szilagyi DE, Smith RF, Elliot JP, Hageman JH (1977) Translumbar aortography. A study of its safety and usefulness. Arch Surg 112:399–408
Thomas M (1981) Smoking and vascular surgery. Br J Surg 68:601–604
Tillgren C (1965) Obliterative arterial disease of the lower limbs. IV. Evaluation of long-term anticoagulant therapy. Acta Med Scand 168:203–219
Tonnesen KH, Sager PH, Gormsen J (1978) Treatment of severe foot ischaemia by defibrination with ancrod: a randomized blind study. Scand J Clin Lab Invest 38:431–435
Vayssairat M, Mathieu JF, Priollet P et al. (1984) Mesure transcutanée de la pression partielle d’oxygène. Une nouvelle méthode d’exploration fonctionnelle en pathologie vasculaire. Presse Med 13:1683–1686
Verstraete M (1982) Current therapy for intermittent claudication. Drugs 24:240–247
Warlow C (1985) Transient ischaemic attacks, current treatment concepts. Drugs 29:474–482
Wetzner SM, Kiser LC, Bezreh JS (1984) Duplex ultrasound imaging: vascular applications. Radiology 150:507–514
Yates CIP, Berent A, Andrews V, Dormandy JA (1979) Increase in leg blood-flow by normovolaemic haemodilution in intermittent claudication. Lancet II:166–168
Zeitler E, Rochter EL. Roth FJ, Schoop W. (1983) Results of percutaneous transluminal angioplasty. Radiology 146:57–60
Anon. (1984) Accidents artériel cérébraux. Rev Prat 34:1091–1154
Anon. (1977) Accidents cérébraux ischémiques trans- itoires. Rev. Prat 27:1–76
Bousser MG, Eschwege E, Hagueneau M et al (1981, 1982, 1983) Essai controlé AICLA. Prévention secon- daire des accidents ischémiques cérébraux liés à l’athéro- sclérose par l’aspirine et le dipyridamole. Rev Neurol 137:333–341, 138:1–5, 139: 335–348
Cambier J, Masson M, Dehen H (1985) Neurologie, 5th edn. Masson, Paris
Canadian Cooperative Study Group (1978) A randomised trial of aspirine and sulfinpyrazone in threatened stroke. N Engl J Med 299:53–59
Candelise L, Lanli G, Perrone P et al. (1982) A randomised trial of aspirine and sulfinpyrazone in patients with TIA. Stroke 13:175–179
Capron L (1984) Epidémiologie et facteurs de risque des accidents artériels cérébraux. Rev Neurol 140:162–170
Collaborative group for the study of stroke in young women (1973) Oral contraception and increased risk of cerebral ischemia or thrombosis. N Engl J Med 288:871–878
Dawber TR, Wolf PA, Thomas HE et al (1975) Epidemiology of cerebral accidents due to atherosclerosis. In: Castaigne P, Lhermitte F, Gauthier JC (eds) Maladies vasculaires cérébrales. Conferences de la Salpé- trière. Baillière, Paris
Derouesne C (1983) Pratique neurologique. Flammarion Paris
Dutreix JL, Genre O, Monegier du Sorbier C et al. (1985) Corrélations ultrasoniques, artériographiques et anato- mo-pathologiques dans 59 cas d’athérosclérose caro- tidienne. Rev Neurol 141:128–136
Fields WS, Lemak AN, Frankowski RF, Hardy RJ (1977, 1978) Controlled trial aspirine in cerebral ischemia. Stroke 8:301–316, 9:309–319
Garde A, Samuelson K, Fahlgren H etal. (1983) Treatment after transient ischemic attacks: a comparison between anticoagulant drug and inhibition of platelet aggregation. Stroke 14:677–681
Gautier JC, Rosa A, Lhermitte F (1975) Auscultation carotidienne. Corrélation chez 200 patients avec 322 angiographies. Rev Neurol 131:175–184
Guiraud-Chaumeil B, Rascol A, David J et al. (1982) Prévention des récidives des accidents vasculaires cérébraux ischémiques par les anti-agrégants plaquettaires. Rev Neurol 138:367–385
Harrison MJG, Pollock S, Kendall BE, Marshall J (1981) Effect of haematocrit on carotid stenosis and cerebral infarction. Lancet II:114–115
Hubert HB, Feinleib M, McNamara PM, Castelli WP (1983) Obesity as an independant risk factor of cardiovascular disease: a 26 year follow-up of participants in Framingham study. Circulation 67:968–977
Humber PR, Leipold GR, Wickbom IG, Bernstein EF (1980) Ultrasonic imaging of the carotid arterial system. AM J Surg 140:199–202
Hypertension detection and follow-up program Cooperative Group (1982) Five year findings of the hypertension detection and follow-up program. III. Reduction of stroke incidence among persons with high blood pressure. JAMA 247:633–638
Kannel WB, Dawber TR, Sorlie P, Wolf PA (1976) Components of blood pressure and risks of ather- othrombotic brain infarction: the Framingham study. Stroke 7:327–331
Kannel WB, Gordon T (1978) Evaluation of cardiovascular risk in the elderly: the Framingham study. Bull NY Acad Med 54:573–591
Kannel WB, Gordon T, Dawber TR (1974) Role of lipids in the development of brain infarction: the Framingham study. Stroke 5:679–685
Kannel WB, Gordon T, Wolf PA, McNamara P (1972) Hemoglobin and the risk of cerebral infarction: the Framingham study. Stroke 3:679–685
Kannel WB, Wolf PA (1983) Epidemiology of cerebrovascular disease. In: Ross RP (ed) Vascular diseases of the central nervous system, Churchill Livingstone, Edinburgh, pp 1–24
Kistler JP, Buonanno FS, Dewitt LD et al. (1983) Application de la résonance magnétique nucléaire à l’étude des maladies cérébro-vasculaires. Presse Med, 48:3086–3090
Laplane D, Josse MO (1983) La chirurgie des sténoses carotidiennes asymptomatiques est-elle légitime? Ann Med Interne 134:663–675
Little JR, Furlan AJ, Modic MT, Weintein MA (1982) Digital substraction angiography in cerebrovascular disease. Stroke 13:557–566
Manelfe C, Ducos de Lahitte M, Marc-Vergnes JP et al. (1982) Investigation of extra-cranial cerebral arteries by intravenous angiography: report of 1000 cases. Am J Neuroradiol 3:287–293
Millikan CH, McDowell FH (1981) Treatment of progressing stroke. Stroke 12:397–409
Moulias R, Congy F, Mercier M et al (1982) l’élévation de l’hématocrite est-elle in facteur de risque vasculaire cérébral? Etude prospective chez 150 sujets ayant eu un accident vasculaire cérébral et chez 150 témoins appariés. Nouv Presse Med II:567–570
Ramollissements cérébraux. Rev Prat 26:595–730
Sorensen PS, Pedersen H, Marquarsden J et al. (1982, 1983) Acetyl salicylic acid in the prevention of stroke in patients with reversible ischemic attacks. Acta Neurol Scand 65:176–177, Stroke 14:15–22
Wolverson MK, Heiberg E, Sundaram M et al. (1982) Carotid atherosclerosis: high-resolution real-time sonography correlated with angiography. Am J Neuroradiol 3:601–607
Zwiebel WL (1982) Comparison of ultrasound and digital substraction arteriography. In: Mistretta CA, Crummy AB, Strother CM, Sacketts JF (eds). Digital substraction arteriography: an application of computerized fluoroscopy. Year Book Medical Publishers, Chicago, pp 45–52
Aldigier JC, Plouin PF, Guyenne TT et al. (1982) Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension. Am J Cardiol 49:1447–1452
Atkinson AB, Brown JJ, Cumming AMM et al. (1982) Captopril in the management of hypertension with renal artery stenosis: its long term effect as a predictor of surgical outcome. Am J Cardiol 49:1460–1466
Ayers CR, Slaughter AR, Smallwood MD et al. (1973) Standards for quality care of hypertensive patients in office and hospital practice. Am J Cardiol 32:533–545
Bech K, Hilden T (1975) The frequency of secondary hypertension. Acta Med Scand 197:65–69
Berglund G, Ove A, Wilhelsen L (1976) Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J ii:554–556
Berthaux P, Beck H, Polet D et al. (1962) Les sténoses des artères rénales chez le vicillard. Sem Hôp Paris 61:3451–3454
Butler AM (1937) Chronic pyelonephritis and arterial hypertension. J Clin Invest 16:889–897
Carey RM, Vaughan ED, Ackerley JA et al. (1978) The immediate pressor effect of saralasin in man. J Clin Endocrinol Metab 46:36–43
Case DB, Wallace JM, Keim HA et al. (1976) Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. Am J Med 61:790–796
Case DB, Wallace JM, Keim HJ et al. (1976) Usefulness and limitations of saralasin, a weak competitive agonist for angiotensin II. for evaluating the renin and sodium factors in hypertensive patients. Am J Med 60:825–836
Dean RH, Kieffer RW, Smith BM et al. (1981) Renovascular hypertension. Anatomic and renal function changes during drug therapy. Arch Surg 116:1408–1415
Dean RH, Shack RB, Rhamy RK et al. (1977) The effect of renal revascularization on kidney function. J Surg Res 22:443–448
Dustan HP, Humphries AW, De Wolfe VG, Page IH (1964) Normal arterial pressure in patients with renal arterial stenosis. JAMA 187:1028–1029
Dustan HP, Page IH, Poutasse EF, Wilson (1963) An evaluation of treatment of hypertension associated with occlusive renal arterial disease. circulation 27:1018–1027
Eyler WE, Clark MD, Garman JE et al. (1962) Angiography of the renal areas including a comparative study of renal arterial stenosis in patients with and without hypertension. Radiology 78:879–891
Gifford RW (1969) Evaluation of the hypertensive patient with emphasis on detecting curable causes. Milbank Q 47:170–186
Golblatt M, Lynch J, Hanzal RF, Summerville WW (1984) Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischaemia. J Exp Med 59:347–379
Grim CE, Luft FC, Weinberger NH, Grim CM (1979) Sensitivity and specificity of screening test for renovascular hypertension. Ann Intern Med 91:617–622
Heptinstall RH, Hill GS (1967) Steroid induced hypertension in the rat. A study of the effects of renal artery constriction on hypertension caused by doxy- corticosterone. Lab Invest 16:751–767
Hillestad L (1968) Systemic arterial hypertension. Aspect of etiology and pathogenesis in a retrospective study of an hospital material. Acta Med Scand 184:225–229
Hodsman GP, Brown JJ, Cumming AMM et al. (1984) Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure renin, angiotensin I and II, renal function and body composition. Am J Med 20:52–60
Hollenberg NF (1983) Medical therapy of renovascular hypertension: efficacy and safety of captopril in 259 patients. Cardiovasc Rev Rep 3:673–676
Hricik DE (1983) Captopril induced functional renal insufficiency in patients with bilateral renal artery stenosis in a solitary kidney. N Engl J Med 308:273–27
Hunt JC, Strong CS (1973) Renovascular hypertension: mechanisms, natural history and treatment. Am J Cardiol 32:562–574
Jamieson CG, Clarkson AR, Wookroffe AJ, Faris I (1984) Reconstructive renal vascular surgery for chronic renal failure. Br J Surg 71(32):338–340
Kjellbo H, Hund N, Bergentz SE, Hood B (1970) Renal artery stenosis and hypertension. Scand J Urol Nephrol 4:43–47
Lagneau P, Michel JB (1981) Arterial reconstructive surgery for renovascular hypertension. Arch Surg 116:999–1002
Menard J, Guyenne TT, Corvol P et al. (1985) Direct immunometric assay of active renin in human plasma. J Hypertension 3:275–278
Messerli FF, Genest J, Nowaczynski W et al. (1975) Hypertension with renal artery stenosis: humoral, hemodynamic and histopathologic factors. Am J Cardiol 36:702–707
Michel JB, Chastang C, Girard J (1982) Apport de la visualisation vasculaire associée à l’urographie intra- veineuse dans le diagnostic de l’hypertension, artérielle. ADELF, Hôpital Necker, Paris
Michel JB, Dussaule JC, Choudat et al. (1986) Renal and hormonal effects of antihypertensive treatment in one clip two kidney hypertension in rats. Kidney Internal 29:1011–1020
Michel JB, Menard J, Dussaule JC et al. (1984) Can the inhibition of the renin angiotensin system have a cardioprotective effect. J Cardiovasc Pharmacol 7:S75–S79
Michel JB, Nussaume O, Valverde JP et al. (1985) Revascularisation renale tardive. J Mal Vasc 10:221–226
Michel JB, Salzmann JL, Ossondo Nlom N et al. (1986) Morphometric analysis of collagen network and plasma perfused capillary bed in the myocardium of rats during evolution of cardiac hypertrophy. Basic Res Cardiol 81:142–155
Noble MJ, Novick AC, Straffon RA, Stewart BA (1979) Aortorenal reimplantation in treatment of renovascular hypertension. Urology 14:566–569
Novick AC, Textor SC, Bodie B, Khauli RB (1984) Revascularization to preserve renal function in patients with atherosclerotic renovascular disease. Urol Clin North Am 11:477–490
Osborne RW, Goldstone J, Hillman BJ (1981) Digital videosubtraction angiography: screening technique for renovascular hypertension. Surgery 90:932–939
Pickering TG, Sos TA, Vaughan ED et al. (1984) Predictive value and changes of renin secretion in patients undergoing successful renal angioplasty. Am J Med 76:398–404
Schreber MJ, Pohi MA, Novick AC (1984) The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 11:383–392
Schwartz CF, White IA (1964) Stenosis of the renal artery: an unselected necropsy study. Br Med J ii: 1415–1421
Sealey JE, Buhler ER, Vaughan ED, Laragh JH (1973) The physiology of renin secretion in essential hypertension: estimation of renin secretion rate and renal plasma flow from peripheral and renal vein renin levels. Am J Med 55:391–401
Simon N, Franklin SS, Bleifer KH, Maxwell MH (1972) Clinical characteristics of renovascular hypertension. JAMA 220:1209–1218
Sos TA, Pickering TG, Saddekni S et al. (1984) The current role of renal angioplasty in the treatment of renovascular hypertension. Urol Clin North Am 11:503–513
Stanley JC, Ernst CB, Fry WJ (1973) Fate of 100 aortorenal vein grafts: characteristics of late graft expansion, aneurysmal dilatation and stenosis. Surgery 74:931–944
Thibonnier M, Joseph A, Sassano P et al. (1984) Improved diagnosis of unilateral renal artery lesions after captopril administration. JAMA 251:56–60
Thibonnier M, Sassano P, Plouin PE et al. (1982) diagnostic value of a single dose of captopril in renin and aldosterone dependent surgically curable hypertension. Cardiovasc Rev Rep 3:1659–1668
Van Velzer DA, Burge CM, Morris GC (1961) Atherosclerotic narrowing of renal arteries associated with hypertension. AJR 86:807–818
Vaughan ED (1985) Renovascular hypertension. Kidney Int 27:811–827
Vaughan ED, Buhler ER, Laragh JH et al. (1973) Renovascular hypertension: renin measurements to indicate hypersecretion and controlateral suppression, estimate renal plasma flow, and score for surgical curability. AM J Med 55:402–414
Vaughan ED, Case DB, Pickering TG et al. (1984) Clinical evaluation for renovascular hypertension and therapeutic decisions. Urol Clin North Am 11:393–408
Wenting GJ, Tan Tjong HL, Derkx FMM et al. (1984) Split renal function after captopril in unilateral renal artery stenosis. Br Med J 288:886–890
Wilson C, Byrom FB (1939) Renal changes in malignant hypertension experimental evidence. Lancet 1:136–139
Wollenveber J, Sheps SG, David DG (1968) Clinical course of atherosclerotic renovascular disease. Am J Cardiol 21:60–71
Ying CY, Tifft CP, Gavras H, Chobanian AV (1984) Renal revascularization in the azotemic hypertensive patient resistant to therapy. N Engl J Med 31:1070–1075
Alpert JS, Braunwald E (1980) Pathological and clinical manifestations of acute myocardial infarction. In: Braunwald E (ed) Heart disease: a textbook of cardiovascular medicine. Saunders, Philadelphia, p 1309
Boulay F (1987) Traitement de l’insuffisance coronaire chromique. In: Gilgenkrantz JM, Royer RJ, Zannad F (eds) Thérapeutique en pathologie cardiovasculaire. Flammarion, Paris, p 565
Bruce RA, Horstein TIR (1969) Exercise testing in evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis 11:371
Cohn PF, Braunwald E (1980) Chronic coronary artery disease. In: Braunwald E (ed) Heart disease: a textbook of cardiovascular medicine. Saunders, Philadelphia, p 1387
De Wood MA, Spores J, Notske R. (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303:897
GISSI(1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1:397
Goldman MJ (1973) Maladie coronarienne; l’infarctus du myocarde. In: Goldman MJ (ed) Electrocardiographic clinique. Vigot, Paris, p 160
Goldman S, Tselos S, Cohn K (1976) Marked depth during treadmill exercise testing: indication of severe coronary artery disease. Chest 69:729
Gruntzig A, Senning A, Siegenthalerwe L (1979) Non operative dilatation of coronary artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 301:61
ISIS-I Collaborative Group (1986) Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS I. Lancet 1:57
Norwegian Multicenter Study Group (1981) Timolol induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304:801
Ogawa H, Hiramori K, Haze K et al. (1985) Classification of non-Q-wave myocardial infarction according to electrocardiographic changes. Br Heart J 54:473
The Persantine-Aspirin Reinfarctus Study Research Group (1980) Persantine and aspirin in coronary heart disease. Circulation 62:449
Sixty Plus Reinfarction Study Research Group (1980) A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 11:989
Sobel BE, Braunwald E (1980) The management of acute myocardial infarction. In: Braunwald E (ed) Heart disease, a textbook of cardiovascular medicine. Saunders, Philadelphia, p 1353
Strauss HW, Harrison K, Langan JK (1975) Thallium- 201 for myocardial imaging. Relation of Thallium-201 to regional myocardial perfusion. Circulation 51:641
Surgery in the treatment of coronary artery disease. Circulation, 1985, Part II, V:72
Wilson RF, Holda MD, White CW (1986) Quantitative angiographic morphology of coronary stenoses leading to myocardial infarction or unstable angina. Circulation 73:286
Zannad F (1987) Limitation pharmacologique de la taille de l’infarctus du myocarde (thrombolyse exclue). In: Gilgenkrantz JM, Royer RJ, Zannad F (eds) Thérapeutique en pathologie cardiovasculaire, Flammarion, Paris, p 594
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fiessinger, J.N., Degos, C.F., Michel, JB., Chatelier, G., Ménard, J., Bonnet, J. (1989). Diagnostic Principles and Therapeutic Management of Patients with Atherosclerosis. In: Camilleri, JP., Berry, C.L., Fiessinger, JN., Bariéty, J. (eds) Diseases of the Arterial Wall. Springer, London. https://doi.org/10.1007/978-1-4471-1464-2_21
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1464-2_21
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1466-6
Online ISBN: 978-1-4471-1464-2
eBook Packages: Springer Book Archive